Total Payments
$31,339
2024 Payments
$6,063
Companies
53
Transactions
1,658
Medicare Patients
14,306
Medicare Billing
$3.5M
Payment Breakdown by Category
Food & Beverage$29,970 (95.6%)
Education$929.28 (3.0%)
Consulting$340.00 (1.1%)
Other$100.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,970 | 1,639 | 95.6% |
| Education | $929.28 | 15 | 3.0% |
| Consulting Fee | $340.00 | 3 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,046 | 246 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,931 | 254 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $2,525 | 123 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,947 | 99 | $0 (2023) |
| GENZYME CORPORATION | $1,824 | 77 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,510 | 76 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,479 | 70 | $0 (2024) |
| Mylan Specialty L.P. | $1,062 | 76 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $1,003 | 49 | $0 (2024) |
| United Therapeutics Corporation | $801.75 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,063 | 270 | AstraZeneca Pharmaceuticals LP ($1,191) |
| 2023 | $5,124 | 265 | AstraZeneca Pharmaceuticals LP ($870.91) |
| 2022 | $4,779 | 251 | AstraZeneca Pharmaceuticals LP ($894.79) |
| 2021 | $4,268 | 229 | AstraZeneca Pharmaceuticals LP ($502.93) |
| 2020 | $2,795 | 147 | AstraZeneca Pharmaceuticals LP ($455.59) |
| 2019 | $3,163 | 184 | AstraZeneca Pharmaceuticals LP ($392.51) |
| 2018 | $2,496 | 152 | GlaxoSmithKline, LLC. ($614.44) |
| 2017 | $2,651 | 160 | GlaxoSmithKline, LLC. ($765.78) |
All Payment Transactions
1,658 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neurology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $9.76 | General |
| Category: Medical Device | ||||||
| 12/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.76 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.55 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Neurology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Immunology | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $88.69 | General |
| Category: HFCWO | ||||||
| 11/25/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $9.11 | General |
| Category: Medical Device | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Immunology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,472 | 36,655 | $2.9M | $1.3M |
| 2022 | 20 | 3,798 | 22,872 | $2.3M | $786,897 |
| 2021 | 19 | 3,838 | 21,080 | $2.2M | $766,574 |
| 2020 | 22 | 3,198 | 19,657 | $2.0M | $669,454 |
Total Patients
14,306
Total Services
100,264
Medicare Billing
$3.5M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2182 | Injection, mepolizumab, 1 mg | Office | 2023 | 24 | 18,434 | $767,000 | $428,437 | 55.9% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 11 | 10,944 | $507,425 | $330,114 | 65.1% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2023 | 11 | 1,292 | $258,000 | $170,638 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 786 | 1,671 | $245,637 | $111,353 | 45.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 138 | 140 | $385,380 | $71,270 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 530 | $110,240 | $51,313 | 46.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 102 | 102 | $323,230 | $49,737 | 15.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 418 | 472 | $46,256 | $21,486 | 46.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 533 | 835 | $40,915 | $17,816 | 43.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 423 | 480 | $34,560 | $16,515 | 47.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $31,320 | $14,657 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 184 | 1,071 | $53,550 | $12,308 | 23.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 53 | 55 | $41,300 | $6,471 | 15.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 81 | 81 | $7,290 | $5,820 | 79.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 83 | 83 | $2,490 | $2,440 | 98.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 153 | 280 | $5,600 | $2,430 | 43.4% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 53 | 58 | $3,132 | $1,537 | 49.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,991 | $944.39 | 47.4% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2022 | 19 | 16,520 | $805,207 | $367,258 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,032 | 1,870 | $274,890 | $131,089 | 47.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 119 | 122 | $408,120 | $64,309 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 371 | 605 | $125,964 | $61,275 | 48.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 109 | 109 | $374,275 | $53,054 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 180 | 180 | $48,600 | $23,631 | 48.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 398 | 452 | $44,296 | $21,675 | 48.9% |
About Dr. An Pham, MD
Dr. An Pham, MD is a Pulmonary Disease healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609848456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. An Pham, MD has received a total of $31,339 in payments from pharmaceutical and medical device companies, with $6,063 received in 2024. These payments were reported across 1,658 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($29,970).
As a Medicare-enrolled provider, Pham has provided services to 14,306 Medicare beneficiaries, totaling 100,264 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Pottstown, PA
- Active Since 02/06/2006
- Last Updated 12/17/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1609848456
Products in Payments
- DUPIXENT (Biological) $3,364
- UPTRAVI (Drug) $1,767
- NUCALA (Biological) $1,676
- FASENRA (Biological) $1,526
- ACTHAR (Biological) $1,293
- TRELEGY ELLIPTA (Drug) $1,238
- SYMBICORT (Drug) $1,060
- STIOLTO RESPIMAT (Drug) $1,007
- BREZTRI (Drug) $882.02
- TEZSPIRE (Biological) $801.20
- XYWAV (Drug) $777.38
- Arikayce (Drug) $707.69
- ELIQUIS (Drug) $633.47
- Xolair (Biological) $609.53
- Wakix (Drug) $608.96
- OPSUMIT (Drug) $570.87
- Yupelri (Drug) $549.07
- (8874) inCourage (Device) $548.94
- TYVASO (Drug) $548.62
- XOLAIR (Biological) $530.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.